EAU 2023 | Effectiveness of photodynamic assessments in non-muscle invasive bladder cancer: real-life study

Rakesh Heer, PhD, FRCS(Urol), Newcastle University. Newcastle upon Tyne, London, discusses non-muscle invasive bladder cancer (NMIBC) and the high rates of recurrence associated with intermediate or high-risk disease. Photodynamic assessments of the bladder were explored as a means to improve tumor clearance and reduce recurrence. While initial evidence suggested potential benefits, real-world clinical practice and standard management approaches, such as chemotherapy washes and BCG treatment, may have masked the observed effects. In response, a pragmatic study was designed to assess the effectiveness of photodynamic assessments in routine practice, considering generalizable inclusion criteria and up-to-date management protocols. This study represents one of the largest contemporary evaluations of this technology in real-life settings. This interview took place at the EAU congress in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.